• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Eradication of syngeneic tumor (Meth A fibrosarcoma) from mice by adoptive immunotherapy of immunized spleen cells induced by Corynebacterium parvum-pyridine extract residue.

作者信息

Mukai K, Horimi T, Orita K

机构信息

First Department of Surgery, Okayama University Medical School, Japan.

出版信息

Acta Med Okayama. 1988 Dec;42(6):301-10. doi: 10.18926/AMO/31006.

DOI:10.18926/AMO/31006
PMID:3266420
Abstract

Eradication of immunologically-syngeneic tumors was achieved by adoptive chemotherapy using effector cells induced by Corynebacterium parvum-Pyridine Extract Residue (CP-PER). A mixture of 2 X 10(6) Meth A cells and 0.1 mg CP-PER was subcutaneously inoculated into the back of donor BALB/c mice, with the result that their spleen cells showed an antitumor effect 10 to 13 days after the inoculation. These cells were used as immune cells. Recipient mice were inoculated with 1 X 10(6) Meth A cells, and 2 days later were administered cyclophosphamide. On the following day, 1 X 10(8) immune cells were adoptively transferred into the recipient mice. As a result, the tumor began to regress 7 to 12 days after the adoptive transfer. An immuno-histochemical study of the donors' spleens and the recipients' regressing tumors revealed that the ratio of L3T4+ T cells to Lyt-2+ T cells in the donors' spleens was increased and that the infiltrating cells in the recipients' tumors were mainly composed of L3T4+ T cells. This confirmed that the transfer of L3T4+ T cells led to the infiltration of L3T4+ T cells into the recipients' tumors, causing their eradication.

摘要

相似文献

1
Eradication of syngeneic tumor (Meth A fibrosarcoma) from mice by adoptive immunotherapy of immunized spleen cells induced by Corynebacterium parvum-pyridine extract residue.
Acta Med Okayama. 1988 Dec;42(6):301-10. doi: 10.18926/AMO/31006.
2
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.环磷酰胺辅助的已建立肿瘤的过继性免疫疗法取决于肿瘤诱导的抑制性T细胞的清除。
J Exp Med. 1982 Apr 1;155(4):1063-74. doi: 10.1084/jem.155.4.1063.
3
Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.细胞间相互作用以及白细胞介素2在同基因小鼠肉瘤免疫表达和诱导中的作用。
J Immunol. 1987 Sep 15;139(6):2103-9.
4
Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
J Immunol. 1989 Jul 15;143(2):740-8.
5
Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.同基因小鼠肉瘤已形成转移灶的过继性T细胞治疗中免疫相互作用的细胞基础。
J Immunol. 1988 Aug 1;141(3):1047-53.
6
Production of interferon-gamma by in vivo tumor-sensitized T cells: association with active antitumor immunity.体内肿瘤致敏T细胞产生γ干扰素:与主动抗肿瘤免疫的关联。
J Interferon Res. 1990 Feb;10(1):1-11. doi: 10.1089/jir.1990.10.1.
7
Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.已建立的同基因实体瘤的过继性免疫治疗:T淋巴细胞亚群的作用
J Immunol. 1984 Apr;132(4):2117-22.
8
The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.“双重移植肿瘤系统”,旨在寻找生物反应调节剂(BRMs)抗肿瘤效应分析中的效应细胞。
Biotherapy. 1989;1(3):139-51. doi: 10.1007/BF02170883.
9
Do L3T4+ T cells act as effector cells in protection against influenza virus infection.L3T4+ T细胞在抵抗流感病毒感染的过程中是否作为效应细胞发挥作用?
Immunology. 1987 Sep;62(1):139-44.
10
Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.从小鼠经OK-432注射的肿瘤部位回收的泛嗜性杀伤细胞进行的过继免疫疗法。
Cancer Res. 1988 Aug 1;48(15):4163-7.

引用本文的文献

1
Immunotherapy in Sarcoma: Future Horizons.肉瘤的免疫疗法:未来展望
Curr Oncol Rep. 2015 Nov;17(11):52. doi: 10.1007/s11912-015-0476-7.